Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Nano Labs (NA) trades at a sub-$50M market cap after a painful drawdown and meaningful corporate restructuring. With CEO open-market buying, a 53.5% cut to operating expenses, a strategic MoU for North American AI infrastructure, and a thin float that magnifies moves, the stock looks actionable on a mid-term long trade. Entry $2.15, stop $1.70, tar…
Susan B. McGee, a director at HIVE Digital Technologies Ltd. (NASDAQ:HIVE), executed a sale of 16,700 common shares on June 3, 2026, according to a recent SEC filing. The transaction was valued at $74,315, with each share sold at $4.45. This sale follows a period of significant analyst activity, where multiple firms have revised their price targets…
Century Aluminum's CEO Jesse Gary will present at the Wells Fargo Industrials and Materials Conference on June 9, 2026, discussing company operations, market conditions, and forward-looking plans including new smelter projects and operational challenges.
Shaunt Voskanian, Chief Revenue Officer at Figma Inc. (NASDAQ: FIG), completed a series of stock sales totaling approximately $2.01 million on June 3, 2026. The transactions were conducted under a Rule 10b5-1 trading plan established on August 6, 2025. This insider activity follows a period of substantial price decline for FIG, which has dropped 11…
Ernst Csiszar, a director at MasTec Inc. (NASDAQ:MTZ), executed a significant stock sale on June 3, 2026, liquidating 6,500 shares for $2,412,605. The transaction occurred at a per-share price of $371.17, shortly after the company's shares experienced a substantial 135% appreciation over the preceding twelve months. Following the divestment, Csisza…
S&P Global Ratings has upgraded Legence Holdings LLC to 'BB-' from 'B+' and assigned a positive outlook, pointing to a significant reduction in financial sponsor ownership and stronger-than-expected first-quarter 2026 results. The upgrade follows debt paydown funded by IPO proceeds and an acquisition that expanded the company's fabrication capacity…
Robinhood Markets, Inc. (NASDAQ: HOOD) Chief Legal Officer Daniel Martin Gallagher Jr. recently executed a series of transactions resulting in the sale of 10,000 Class A Common Stock shares. The divestment, valued at $836,771, was carried out on June 3, 2026, utilizing a Rule 10b5-1 trading plan established in August 2025. This move occurs amidst a…
Equillium, Inc. (NASDAQ: EQ) reported that Chief Operating Officer Christine Zedelmayer sold 14,584 shares of the company's common stock on June 5, 2026. The sale, valued at approximately $42,736, was executed under a Rule 10b5-1 trading plan adopted in August 2025. This transaction occurred shortly after Zedelmayer exercised employee stock options…
Entities affiliated with American Securities LLC executed significant sales of SOLV Energy (NASDAQ: MWH) securities on June 4, 2026, totaling approximately $67.77 million. The transactions, part of a follow-on public offering, involved both direct share sales and derivative interest exchanges. These moves occur against a backdrop of SOLV Energy's r…
American Securities LLC and its affiliated entities, acting as 10% owners of SOLV Energy, Inc. (NASDAQ:MWH), executed a significant divestiture on June 4, 2026. The transactions, stemming from the full exercise of underwriters' options in a follow-on public offering, generated $67.77 million in proceeds from the sale of 1,882,525 shares and interes…
Allison Swartz, Executive Vice President and General Counsel at Progyny, Inc. (NASDAQ: PGNY), has reported the sale of company stock through a Rule 10b5-1 trading plan. The transactions, executed in early June 2026, involve the disposition of shares to cover tax obligations and sales under the automated plan, totaling approximately $70,473. This ac…
Progyny, Inc. (NASDAQ: PGNY) Chief Financial Officer Mark S. Livingston executed a series of stock transactions in early June 2026, selling shares under a Rule 10b5-1 plan while simultaneously having restricted stock units withheld for tax obligations. These administrative sales occur against a backdrop of significantly improved financial metrics, …
Offerpad Solutions Inc. (NASDAQ: OPAD) CEO Brian Bair has increased his ownership stake in the company through a recent purchase of 122,920 shares, even as the stock has declined significantly over the past six months. The transaction occurred alongside a 1-for-10 reverse stock split and the release of Q1 2026 earnings, which showed improved gross …
dLocal Limited, a cross-border payment platform focused on emerging markets, announced it will release its second quarter 2026 financial results on August 13, 2026, followed by a conference call and webcast. The company facilitates global payment infrastructures connecting enterprises to local markets in Africa, Asia, the Middle East, and Latin Ame…
A stronger-than-expected May jobs report stoked fears that U.S. interest rates could remain higher for longer, prompting investors to pull back from high-flying technology names, safe-haven government debt and gold. The Nasdaq suffered its steepest one-day fall in over a year, while semiconductors and several top chipmakers posted heavy losses afte…
Mark Dorfman, serving as Executive Vice President, General Counsel, and Secretary at Leonardo DRS, Inc. (NASDAQ: DRS), executed a sale of 5,536 shares of the company's common stock on June 4, 2026. The transaction, valued at $253,272, was conducted at a price of $45.75 per share. This sale occurs against a backdrop of significant stock appreciation…
Gene Munster of Deepwater Asset Management views Apple's Worldwide Developers Conference as a potential catalyst to rerate the company's stock if the firm can demonstrate AI features that reposition it from an AI follower to a leader in personalized AI. The event is expected to highlight a redesigned Siri, built over nearly two years, that leverage…
Gilmore O'Neill, Chief Executive Officer of Editas Medicine, Inc. (NASDAQ: EDIT), sold 15,380 shares of common stock totaling $41,542 on June 3, 2026, according to a recent Form 4 filing with the Securities and Exchange Commission. The sale was executed at a weighted average price of $2.7011 per share, with individual trades occurring within a pric…
Amy Parison, the Senior Vice President and Chief Financial Officer at Editas Medicine, Inc. (NASDAQ: EDIT), has reported the sale of company common stock. The transaction, executed on June 3, 2026, involved 464 shares sold at prices ranging from $2.7010 to $2.7049 per share, resulting in a total value of $1,253. The sale was not discretionary but w…
U.S. stock markets ended Friday under pressure, led by declines in technology, basic materials and oil and gas names. The Dow fell 1.35%, the S&P 500 lost 2.64% and the Nasdaq Composite slid 4.18% at the New York close. A number of large-cap technology names were among the heaviest decliners, while consumer staples and insurers provided some relati…
The S&P/TSX Composite closed lower, falling 2.28% as losses in the Materials, Information Technology and Energy sectors weighed on the Toronto market. A small group of stocks produced gains, while several names recorded steep declines, including TerraVest Industries, which dropped to 52-week lows.
Brazil's main share index closed lower on Friday, with the Bovespa dropping 0.77% to a fresh three-month low. Losses were concentrated in the Basic Materials, Real Estate and Electric Power sectors. Market breadth was negative, with more decliners than advancers, while several individual stocks recorded sizable percentage moves in both directions. …
DBV Technologies announced that CEO Daniel Tassé will participate in a fireside chat at the upcoming Goldman Sachs 47th Annual Global Healthcare Conference. The company is advancing its proprietary VIASKIN® patch technology for treating food allergies, focusing on clinical trials for peanut allergy in young children. The event will be webcast live …
Life Time Group Holdings Inc. faces renewed market scrutiny following a significant insider transaction by director John G. Danhakl, who liquidated over 2.2 million shares in early June 2026. While the sale represents a substantial reduction in holdings through affiliated entities, recent analyst upgrades and operational expansions suggest continue…
Aldeyra Therapeutics CEO Todd Brady has purchased a substantial stake in the company, signaling confidence despite recent regulatory and financial challenges. The acquisition follows a Complete Response Letter from the FDA regarding reproxalap and a downgrade by H.C. Wainwright, while BTIG maintains a Buy rating.
